What question did this study set out to answer?

The research aims to understand how genetic factors and their interactions influence metabolic dysfunction-associated steatotic liver disease (MASLD).

March 4, 2026BMC Medical GenomicsOpen Access

Genetic modulators of metabolic dysfunction-associated steatotic liver disease (MASLD) and their epistatic interactions: from in vitro and animal models to clinical outcomes

View Full Paper

Ask AI

Bookmark

Authors

FAFernanda Guadalupe Arriaga-GonzálezAutonomous University of Queretaro FCFelipe de Jesús Castañeda-CórdovaAutonomous University of Queretaro MDMauricio Díaz‐MuñozAutonomous University of Queretaro

Discussion

Member takes

Implication

This review explores genetic influences on metabolic dysfunction-associated steatotic liver disease, indicating new insights for personalized therapies.

Key Points

The research aims to understand how genetic factors and their interactions influence metabolic dysfunction-associated steatotic liver disease (MASLD).
Review of existing literature on MASLD and genetic influences
Analysis of in vitro and animal models
Discussion of clinical outcomes related to genetic variants
Nearly one-third of the global population is affected by MASLD with a rising incidence due to lifestyle factors
Key genetic variants like PNPLA3 and TM6SF2 are linked to disease severity
Protective genetic alleles can mitigate progression of MASLD despite adverse risk factors
Epistatic interactions among genes may enhance predictive accuracy of polygenic risk scores

Cite This Study

Arriaga-González et al. (2026) studied this question.

synapsesocial.com/papers/69a7cd1dd48f933b5eed9328 https://doi.org/10.1186/s12920-026-02332-7

View Full Paper

Ask AI

Bookmark

Implication

This review explores genetic influences on metabolic dysfunction-associated steatotic liver disease, indicating new insights for personalized therapies.

Genetic modulators of metabolic dysfunction-associated steatotic liver disease (MASLD) and their epistatic interactions: from in vitro and animal models to clinical outcomes

Discussion

Member takes

Implication

Key Points

Cite This Study

Genetic modulators of metabolic dysfunction-associated steatotic liver disease (MASLD) and their epistatic interactions: from in vitro and animal models to clinical outcomes

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider